Miach Orthopaedics is transforming ACL treatment with the innovative BEAR® Implant, the first medical technology designed to restore a patient's own ACL instead of replacing it. Developed at Boston Children's Hospital by Dr. Martha Murray, with support from the NFL Players Association and the NIH, the BEAR Implant marks a major advancement in orthopedic care by promoting natural healing and preserving native tissue.
The BEAR® Implant by Miach Orthopaedics is a groundbreaking advancement in ACL treatment, offering the first FDA-approved solution that helps the body heal its own torn ACL. Unlike traditional reconstruction, which replaces the ligament with graft tissue, the BEAR Implant works by bridging the torn ends and promoting natural healing. Developed through years of research at Boston Children's Hospital, this innovative technology preserves native tissue, reduces donor site complications, and supports faster recovery-making it a game-changer in sports medicine and orthopedic surgery.
